OTCMKTS:FSDDF FSD Pharma (FSDDF) Stock Price, News & Analysis $4.88 -0.13 (-2.59%) As of 05/8/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About FSD Pharma Stock (OTCMKTS:FSDDF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FSD Pharma alerts:Sign Up Key Stats Today's Range$4.70▼$5.0150-Day Range$2.10▼$5.6552-Week Range$3.43▼$68.66Volume118,020 shsAverage Volume11,100 shsMarket Capitalization$36.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview FSD Pharma Inc. is a clinical‐stage pharmaceutical company focused on the research, development and commercialization of cannabinoid‐based drug formulations and wellness products. Its team combines expertise in pharmaceutical R&D and cannabis science to advance novel therapeutic candidates derived from cannabidiol (CBD) and related cannabinoids. Through Canadian subsidiaries holding production licenses under the Cannabis Act, FSD Pharma operates extract and formulation facilities that manufacture full‐spectrum CBD oils, topicals and nutraceuticals. The company also collaborates with contract research organizations and academic partners to support preclinical studies and early‐phase clinical trials targeting a range of therapeutic areas. FSD Pharma distributes medical and wellness offerings across North America and has pursued partnerships and licensing agreements to extend its presence into Europe and other regulated markets. By integrating in‐house production capabilities with third‐party distribution networks, it aims to serve both patient and consumer segments with pharmaceutical‐grade cannabinoid solutions. Incorporated in Canada and trading on the OTC market under the ticker FSDDF, FSD Pharma is guided by a management team with backgrounds in pharmaceutical development, regulatory affairs and cannabis cultivation. The company continues to build its pipeline through strategic alliances, positioning itself within the emerging global cannabinoid therapeutics sector.AI Generated. May Contain Errors. Read More Receive FSDDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FSDDF Stock News HeadlinesFreya Pharma Solutions Strengthens Leadership with Appointment of Distinguished Supervisory BoardJanuary 28, 2025 | markets.businessinsider.comQNTM Quantum BioPharma Ltd.August 31, 2024 | seekingalpha.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.May 12 at 1:00 AM | InvestorPlace (Ad)FSD Pharma Inc. (HUGE)May 17, 2024 | finance.yahoo.comFSD Pharma Inc. Obtains Final Order for Plan of ArrangementNovember 27, 2023 | benzinga.comFSD Pharma gets court complaint alleging breach of nondisclosure agreementMay 12, 2023 | msn.comFSD Pharma Inc Ordinary Shares - Class B (Sub Voting)March 31, 2023 | morningstar.comMFSD Pharma's Australian Entity To Proceed With Phase I Trial For Major Depressive DisorderMarch 23, 2023 | benzinga.comSee More Headlines FSDDF Stock Analysis - Frequently Asked Questions How have FSDDF shares performed this year? FSD Pharma's stock was trading at $7.33 at the beginning of the year. Since then, FSDDF stock has decreased by 33.4% and is now trading at $4.88. How do I buy shares of FSD Pharma? Shares of FSDDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Agricultural Commodities & Milling Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:FSDDF Previous SymbolOTCMKTS:FSDDF CIKN/A WebN/A Phone(416) 854-8884FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.81 Quick Ratio1.60 Sales & Book Value Annual Sales$70 thousand Price / Sales528.43 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares7,580,000Free FloatN/AMarket Cap$36.99 million OptionableNot Optionable BetaN/A Don't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:FSDDF) was last updated on 5/12/2026 by MarketBeat.com Staff. From Our PartnersIran broke the petrodollar…For 50 years, every barrel of oil settled in dollars - that rule is what made the dollar the world's reserve c...Golden Portfolio | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...Huge Alerts | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredIf You Have $50k+ on Coinbase, This Will Ruin Your DayIn 2009, Greece's debt-to-GDP ratio hit 130%. Within 24 months... Pensions were slashed 40% overnight. Bank ac...Decentralized Masters | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share FSD Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
